ProQR Therapeutics N.V.
Calidad de datos: 17%
PRQR
Nasdaq
Manufacturing
Chemicals
$1.85
▼
$0.13
(-6.57%)
Cap. Mercado: 207.03 M
Precio
$1.97
Cap. Mercado
207.03 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Valoración
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | — | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.3 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Precio Objetivo de Analistas
8 analistas
Buy
Actual
$1.85
Objetivo
$8.88
$4.00
$8.50
$14.00
Pronóstico
EPS Futuro
-$0.71
Ingresos Est.
17.90 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$0.71
-$1.05 – -$0.42
|
17.90 M | 6 |
| FY2026 |
-$0.59
-$0.82 – -$0.43
|
22.56 M | 8 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
-$0.15
-$0.17 – -$0.13
|
5.77 M | 7 |
| 2026 Q1 |
-$0.14
-$0.16 – -$0.09
|
6.14 M | 7 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | -$0.12 | -$0.09 | +21.2% |
| Q32025 | -$0.17 | -$0.12 | +29.1% |
| Q22025 | -$0.09 | -$0.14 | -49.9% |
| Q12025 | -$0.16 | -$0.11 | +30.7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 207.03 M | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
{"event":"ticker_viewed","properties":{"ticker":"PRQR","listing_kind":"stock","pathname":"/stocks/prqr","exchange":"Nasdaq","country":"US"}}

